It has been reported that the serum level of L-xylulose (1) and D-glucaric acid (2) and the urinary excretion of D-glucuronic acid (3, 4) and D-glucaric acid (5) were markedly increased in diabetic patients, and that the relative contribution of the glucuronic acid pathway to D-glucose catabolism as shown in Fig. 2 was greater in adipose tissue from al loxan diabetic rats than from normal ones (6, 7) . These results suggest that the activity of the D-glucuronic acid--L-xylulose route is enhanced in diabetes. However these results are contrary to the findings that the activity of the glucuronic acid pathway was reduced in the diabetic liver in the two enzymatic steps, dehydrogenation of UDPG (Uridine di phosphate glucose) and the pathway from D-glucuronic acid to L-xylulose (8, 9) . Thus the activity of this pathway in diabetes is still uncertain. In the present study, the authors attempted to elucidate the dynamic aspects of the glucuronic acid pathway in alloxan diabetic rabbits. Chemical Center and 6-14C-glucuronolactone was prepared according to the following method. 6-14C-Potassium D-glucuronate (284 /-imole, 15.5 1,eCi/mg) was diluted with 100 /,zmole of sodium D-glucuronate and dissolved in water. The solution was passed through a column of Amberlite CG-120 to convert to free acid and the column was washed with 3 ml of water containing 100 ,pole of sodium D-glucuronate. The eluted solution was evaporated to dryness in macro at 50°C. Glacial acetic acid and unlabeled D-glucurono lactone were added. The acidic solution was boiled at 100'C for 30 min. After cooling, the crystals obtained had a specific activity of 0.74 ppCi/mg.
MATERIALS AND METHODS

D-Glucaric
Experimental animals
Healthy male albino rabbits bred in our laboratories, weighing 2.8 to 3.2 kg, were injected i.v. with alloxan monohydrate (100 mg/kg body weight) dissolved in Ringer's solution. These animals were fed 150 g of RC-5 (Oriental Yeast Co., Ltd., Tokyo) and 100 g of carrots a day. The onset of diabetes was determined by measuring the increase in blood glucose level and urinary glucose contents, and the loss in body weight and by checking for polyuria and polydipsia. The animals were not employed until at least 4 weeks after the injection of alloxan and only if the fasting blood glucose level exceeded 250 mg per 100 ml of blood.
Protamine-Zinc-Insulin was injected s.c. in a dosage of 5 unit per 1.0 g urine glucose per day, and the animal was used for studies at least 16 hours later.
Collection of expired 14CO2
Each animal was immediately placed in a metabolic chamber which was designed to permit periodic collection of expired carbon dioxide in monoethanolamine.
Measurement of radioactivity
The expired 14CO2 was assayed for radioactivity in the form of ethanolamine carbonate.
The scintillator solution contained 4 g PPO, 0.2 g POPOP, 600 nil 2-methoxyethanol, and 300 ml of toluene. Two nil of ethanolamine carbonate, 0. 1 ml of urine, or 0. 1 ml of the elute from Dowex 1 8 (borate type) column were added respectively to each vial con taining 12 ml scintillator solution and the radioactivity was measured in Nuclear Chicago Mark I liquid scintillation counter.
Separation of urinary metabolites
The metabolites were applied on a 1.0 4.5 cm column of Dowex 1 8 resin. Dowex 1 ; 8 (borate type) was prepared from Dowex 1 8 ( ,chloride type) by the method of Ishidate (10) . The metabolites of D-glucuronic acid were separated by the method of Fujita (11) . Deter•rrrirratiorr of the urinary metabolites Separated D-glucuronic acid was determined by naphthoresolcinol reaction (12) . D Glucaric acid was determined by the method of Ishidate (10) . Ketose was isolated and determined by cysteine-carbazole-H2SO4 reaction (13) and the method of Kulka (14) . Preparation of tissue for enzyme measurements For the measurement of enzymatic activity 25%, homogenate was prepared from rab bit liver. The homogenizing medium was ice-cold 0.154 M KCI solution. The homo genate was centrifuged for 20 min at 6,000 xg to remove all nuclei and cell debris. The supernatant thus obtained was subjected to ultracentrifugation at 105,000 x g for 90 min. The supernatant fluid was used for assay of D-glucuronolactone-, L-gulonic acid-, NADP L-hexonate-, and U DPG-dehydrogenase and lactonase II activities. The sediment was washed with 0.154 M KCl and centrifuged again as above. The microsomal fractions finally were suspended in 0.154 M KC1 and used for assay of UDPGA-transferase.
The supernatant fraction collected after centrifugation at 6,000 x g from 25% homo genate in 0.154 M KCl and 1.0% homogenate in distilled water assayed for UDPGA pyrophosphatase and Q-glucuronidase activities, respectively. All subsequent steps were carried out at 0-4°C.
Enzyme assays
The following enzyme activities were measured by the methods as indicated in the references: D-Gluculonolactone dehydrogenase (15), L-gulonic acid dehydrogenase (16), UDPG-dehydrogenase (17), NADP-L-hexonate dehydrogenase (18), UDPGA-pyrophos phatase (19) , D-glucuronic acid-l-phosphate phosphatase (20) , Q-glucuronidase (21), and lactonase 11 (22) . UDPGA-transferase was assayed by a modified method of Isselbacher (23) . In the UDPGA-transferase reaction mixture, 5 ,nmole of D-glucaro-1, 4-lactone was added as the inhibitor of ~-glucuronidase contained in this enzyme. Serum j -glucuronidase was assayed according to Shioya (24) . All enzymes were assayed at 37°C. (25), and glucose oxidase method (26) . Urinary glucose content was determined by the method of Fujii (27) . Determination of protein Protein was determined by the method of Warburg and Christian (28) , and by the biuret method (29) .
RESULTS
Urinary excretion of D-glucuronic acid, D-glucaric acid, and L-ascorbic acid
The results in normal and diabetic rabbits are summarized in Table 1 . The amount of urinary excretion of D-glucuronic acid, D-glucaric acid, and L-ascorbic acid was higher in the diabetic animals than in the normal ones, respectively in the 24-hr urine.
Conversion to D-glucaric acid front D-gltrcuronoluctoire
The transformation from D-glucuronolactone to D-glucaric acid in normal and dia betic rabbits was studied following both oral and intravenous administration of the lac tone. Table 2 shows that the conversion rate of administered D-glucuronolactone to D glucaric acid was higher in the diabetic animals than normal. 
Excretion of radioactivity after the administration of 6-14C-glucuronolactone
The excretion pattern (urine and expired air) has been studied following both oral and intravenous administration of 6-14C-glucuronolactone. In Table 3 , its shown that the expired 14C02 was significantly decreased in the diabetic rabbits, and the decrease was nearly returned to normal level as a result of insulin treatment.
The radioactivity of the urine was increased in the diabetic animals, and it was re turned to the normal level by insulin treatment.
Fractionation of the urine by Dowex l x 8 resin column
Analyses of the radioactivity excreted in the urine after the oral administration of 6-14C-glucuronolactone are shown in Fig. 1 .
In Fig. 1 , peak (I), (II), (III), (IV) and (V) correspond to D-glucose and D-fructose, L-gulonic acid, D-glucuronic acid, D-glucaric acid, and D-gluconic acid, respectively. In the normal and diabetic rabbit, radioactivity was observed in the peak of (Ill) and (IV), and (II), (III) and (IV), respectively.
The results of the fractionation by Dowex column are summarized in Table 4 . In bits. Conversely, the activity of L-gulonic acid dehydrogenase, lactonase II, (3-glucuro nidase, and U DPG-dehydrogenase was remarkably reduced in the diabetic rabbits.
D-Glucuronolactone dehydrogenase activity was unchanged. NADP-L-Hexonate dehydrogenase activity was reduced in the diabetic rabbits.
DISCUSSION
The increase in the excretion of both D-glucaric acid and L-ascorbic acid provides evidence for the accumulation of endogenous D-glucuronic acid in diabetic rabbits. En dogenous D-glucuronic acid could be formed in the living body, via the direct hydrolysis of UPDGA by UDPGA-pyrophosphatase (30), the hydrolysis of glucuronide by 8-glu curonidase (31), the oxidation of myo-inositol (32) , and the hydrolysis of mucopolysac charides (33, 34) . The possible role of the (-glucuronidase route in the release of D-glu curonic acid from UDPGA has been the subject of many discussions (31, 35, 36) . In these discussions, the increased excretion of endogenous D-glucuronic acid found in their experiments was explained by increased hepatic Q-glucuronidase activity. However , in our experiments, hepatic /l-glucuronidase activity was markedly reduced in the diabetic animals. The fact that the hepatic f -glucuronidase activity was significantly reduced The present study indicates that the urinary excretion of D-glucuronic acid, D-glucaric acid and L-ascorbic acid was considerably increased in the diabetic rabbit. The results in the excretion of D-gluculonic acid and D-glucaric acid are in agreement with the obser vation of other investigators (3) (4) (5) , however, the findings in L-ascorbic acid excretion dif fer from the evidence given by Stirpe (37) for an impaired synthesis of L-ascorbic acid in the liver of alloxan diabetic animals.
Burns (38) reported that the administration of 6-14C-glucuronolactone increased uri nary excretion in the normal rat and guinea pig by 2-3 of the dose. In the present in vestigation, urinary labeled L-gulonic acid was significantly increased when 6-14C-glucu ronolactone was administered to the diabetic rabbits. Furthermore, intravenous ad ministration of 6-14C-glucuronolactone resulted in a greater increase of radioactive L gulonic acid (II) as compared with the oral dose. (data not included). In these experi ments, there was a marked decrease in the expired 14C02 from the diabetic rabbits after oral administration of 6-14C-glucuronolactone. These results indicate that decarboxy lation of L-gulonic acid to L-xylulose was depressed as a result of the decreased L-gulonic acid dehydrogenase activity in the diabetic animals.
The enzymatic dehydrogenation of D-glucuronolactone in the diabetic rabbit liver remained unchanged (Table 6) , while the conversion rate to D-glucaric acid increased in the diabetic rabbit (Table 2) . This indicates that an impairment in catabolism of D-glucuronic acid may occur in the diabetic liver.
Injection of insulin to the diabetic rabbits elevated above normal the level of radio activity in D-glucaric acid (IV) after oral administration of 6-14C-glucuronolactone and this level of radioactivity remained elevated in the case of intravenous administration of the lactone also. (data not included) Our experiments do not completely rule out the possibility that D-glucuronolactone is also dehydrogenated by an enzyme in the intestine, or that insulin does effect the dehydrogenase activity. Additional experiments to clarify this point are underway.
It has been shown that the metabolism of D-glucose via the glucuronic acid pathway in diabetes mellitus is more active than that in normal (1-7), whereas our data showed that the activity of the glucuronic acid pathway decreased in the alloxan diabetic rabbit. It appears that principally the decreased activity of the glucuronic acid pathway in the dia betic rabbits is due to the reduced activity of L-gulonic acid dehydrogenase. Our experi ments demonstrated that as a result of reduced L-gulonic acid dehydrogenase activity in the diabetic animals, endogenous D-glucuronic acid increases. This is accompanied by an increase in the synthesis of D-glucaric acid and L-ascorbic acid. Also the reduced L-gulonic acid dehydrogenase activity produces an increase of L-gulonic acid excretion and reduced decarboxylation of 6-14C-glucuronolactone in the diabetic rabbit.
In conclusion, certain metabolic abnormalities in the alloxan diabetic rabbits can be, at least in part, attributed to a defect in the step of L-gulonic acid dehydrogenation and to the enhancement of UDPGA-pyrophosphatase and D-glucuronic acid I -phosphate phosphatase activity (Fig. 2) .
